SCHEMBL14090268

SCHEMBL14090268

CC(C)(C)OC(=O)NCC[C@H](NC(=O)[C@@H](N)Cc1ccc(F)c(F)c1)C(=O)NCc1ccccc1

nearest known ligand 0.49

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
▸ CA1 P00915 3/20 0.49
▸ CA2 P00918 3/20 0.49
▸ KLKB1 P03952 1/20 0.45
▸ CTSS P25774 10/20 0.44
▸ CTSK P43235 10/20 0.44
▸ CTSB P07858 4/20 0.43
▸ PSMB8 P28062 2/20 0.43
▸ PSMB9 P28065 2/20 0.43
▸ PSMB5 P28074 2/20 0.43
▸ CTSL P07711 2/20 0.43
▸ MMP1 P03956 1/20 0.42
▸ MMP3 P08254 1/20 0.42
▸ MMP9 P14780 1/20 0.42
▸ PSMB1 P20618 1/20 0.41
▸ PSMB10 P40306 1/20 0.41
▸ PSMB2 P49721 1/20 0.41
▸ AKT1 P31749 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14583981 0.86 KLKB1 (0.47) CA1CA2KLKB1PSMB8PSMB9
SCHEMBL12340141 0.82 CTSS (0.57) CA1CA2KLKB1CTSSCTSK
SCHEMBL12340145 0.79 CTSS (0.53) CA1CA2KLKB1CTSSCTSK
SCHEMBL14583979 0.79 KLKB1 (0.43) KLKB1PSMB8PSMB9PSMB5PSMB1
SCHEMBL14485298 0.78 ATM (0.53) CA1CA2CTSSCTSKCTSB
SCHEMBL14485300 0.78 ATM (0.53) CA1CA2CTSSCTSKCTSB
SCHEMBL3584002 0.78 CTSK (0.50) CA1CA2CTSSCTSKCTSB
SCHEMBL2921238 0.78 CTSK (0.50) CA1CA2CTSSCTSKCTSB
SCHEMBL3188590 0.77 CTSK (0.60) CA1CA2CTSSCTSKCTSB
SCHEMBL22236519 0.77 CTSS (0.63) CA1CA2CTSSCTSKCTSB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7417030-B2 Indazole peptidomimetics as thrombin receptor antagonists ORTHO-MCNEIL PHARMACEUTICAL, INC. (US) 2008-08-26 — — US disclosed
US-7417030-B2 Indazole peptidomimetics as thrombin receptor antagonists ORTHO-MCNEIL PHARMACEUTICAL, INC. (US) 2008-08-26 — — US disclosed
Send feedback